There is a large opportunity many companies are still yet to seize in this area.
Read moreNICE’s Highly-Specialised Technologies (HST) process is a method for evaluating medicines and trea...
Read moreNICE has set out its plan using four key pillars designed to elicit incremental change within the UK...
Read moreSecuring patient access in specialty products is becoming increasingly challenging due to the comple...
Read moreReal-world evidence (RWE) is increasingly playing an important role in developing product value prop...
Read moreThe highly specialised technologies (HST) process was introduced in 2013 for the purpose of evaluati...
Read moreRemap Consulting has significant expertise in guiding companies through both EUnetHTA / EMA Parallel...
Read moreWithin the last few months, the significant changes proposed to the Italian pricing and reimbursemen...
Read moreRelative Effectiveness Assessment (REA) is a type of assessment that evaluates the effectiveness of ...
Read more